| dbo:abstract
|
- Vibralactones are a group of related terpenoid chemical compounds, the first of which were isolated from the Basidiomycete in 2006. Additional vibralactones have also been isolated from the fungus Stereum hirsutum. Vibralactone A has attracted research interest because it is an inhibitor of pancreatic lipase (IC50 0.4 μg/mL) with in vitro activity comparable to that of the obesity drug orlistat. Several laboratory syntheses of vibralactone A have been developed. (en)
|
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 2468 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:caption
|
- Vibralactone A (en)
- Vibralactone B (en)
- Vibralactone C (en)
- Vibralactone D (en)
- Vibralactone E (en)
- Vibralactone F (en)
|
| dbp:height
| |
| dbp:image
|
- Vibralactone B.svg (en)
- Vibralactone C.svg (en)
- Vibralactone D.svg (en)
- Vibralactone E.svg (en)
- Vibralactone F.svg (en)
- Vibralactone.svg (en)
|
| dbp:perrow
| |
| dbp:width
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdfs:comment
|
- Vibralactones are a group of related terpenoid chemical compounds, the first of which were isolated from the Basidiomycete in 2006. Additional vibralactones have also been isolated from the fungus Stereum hirsutum. Vibralactone A has attracted research interest because it is an inhibitor of pancreatic lipase (IC50 0.4 μg/mL) with in vitro activity comparable to that of the obesity drug orlistat. Several laboratory syntheses of vibralactone A have been developed. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
